Maria Alice Willrich, Ph.D., explains how Mayo Clinic Laboratories' new assay provides therapeutic drug monitoring of risankizumab, or RISA. Test results help guide care for patients with plaque psoriasis, psoriatic arthritis, and Crohn's disease.

(00:32)
 Do you mind giving the audience more information about yourself and your background?

 

(01:53)
 Could you please give a brief overview of this assay?

 

(03:35)
 Which patients should have this testing and when should it be performed?

 

(04:57)
 How are the results used in patient care?

 

(06:59)
 Other monoclonal antibody therapies are usually monitored by a combination of drug quantification and analysis of antidrug antibodies. How is this test being offered?